Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
10206-1 Physical findings Find Skin Pt Nar Observed   ACTIVE Physical findings of Skin Narrative   MIN DefinitionDescription                   H&P.PX   10206-1   Observed             0 Phys find Skin           Dermatologic; Epidermis; Exam; Examination; Finding; Findings; H+P; H+P.PX; Integument; Narrative; P prime; Phys find; Point in time; Random; Report; Skn 2.4 1.0i                       0
102060-1 Perfluoroheptanoate MCnc Ser/Plas Pt Qn LC/MS/MS   ACTIVE Perfluoroheptanoate [Mass/volume] in Serum or Plasma by LC/MS/MS   NAM DefinitionDescription     ng/mL             DRUG/TOX   102060-1   LC/MS/MS     Observation       0 PFHpA SerPl LC/MS/MS-mCnc       N   DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Perfluoroenanthic Acid; PFHpA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tridecafluoroheptanoic acid 2.77 2.75               ng/mL     Release 2.77: COMPONENT: changed to the anionic name per the Users' Guide section 2.1.2.13; 0
102061-9 4,8-Dioxa-3H-perfluorononanoate MCnc Ser/Plas Pt Qn LC/MS/MS   ACTIVE 4,8-Dioxa-3H-perfluorononanoate [Mass/volume] in Serum or Plasma by LC/MS/MS   NAM DefinitionDescription     ng/mL             DRUG/TOX   102061-9   LC/MS/MS     Observation       0 ADONA SerPl LC/MS/MS-mCnc       N   4,8-Dioxa-3H-perfluorononanoic acid; ADONA; DRUG/TOXICOLOGY; Drugs; DTXSID40881350; Level; Mass concentration; PFNA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.77 2.75               ng/mL     Release 2.77: COMPONENT: changed to anionic name per users' guide section 2.1.2.13); 0
102062-7 Sum of branched perfluorooctanoate isomers MCnc Ser/Plas Pt Qn LC/MS/MS   ACTIVE Branched PFOA isomers [Mass/volume] in Serum or Plasma by LC/MS/MS   ADD DefinitionDescription     ng/mL             DRUG/TOX   102062-7   LC/MS/MS     Observation       0 Sb-PFOA SerPl LC/MS/MS-mCnc       N   DRUG/TOXICOLOGY; Drugs; FC-143 component; Level; Mass concentration; Pentadecafluorooctanoic acid; PFOA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Sb-PFOA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.75 2.75               ng/mL       0
102063-5 n-Perfluorooctanoate MCnc Ser/Plas Pt Qn LC/MS/MS   ACTIVE Linear PFOA Isomer [Mass/volume] in Serum or Plasma by LC/MS/MS   NAM DefinitionDescription     ng/mL             DRUG/TOX   102063-5   LC/MS/MS     Observation       0 n-PFOA SerPl LC/MS/MS-mCnc       N   DRUG/TOXICOLOGY; Drugs; FC-143 component; Level; Mass concentration; n-PFOA; Pentadecafluorooctanoic acid; PFOA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.77 2.75               ng/mL     Release 2.77: COMPONENT: changed to the anionic name per the Users' Guide section 2.1.2.13; 0
102064-3 Total perfluorohexanoic acid isomers MCnc Ser/Plas Pt Qn     ACTIVE Total perfluorohexanoic acid isomers [Mass/volume] in Serum or Plasma   NAM DefinitionDescription     ng/mL     Calculation: Sum of Branched PFOA Isomers and Linear PFOA Isomer results       DRUG/TOX   102064-3         Observation       0 Total PFOA Isomers SerPl-mCnc       N   Acd; Acids; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Total PFOA Isomers; Totl 2.77 2.75               ng/mL     Release 2.77: COMPONENT: removed abbreviation for the name of the isomer; 0
102065-0 Perfluorohexane sulfonate MCnc Ser/Plas Pt Qn LC/MS/MS   ACTIVE Perfluorohexane sulfonate [Mass/volume] in Serum or Plasma by LC/MS/MS   NAM DefinitionDescription     ng/mL             DRUG/TOX   102065-0   LC/MS/MS     Observation       0 PFHxS SerPl LC/MS/MS-mCnc       N   DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; PFHxS; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.77 2.75               ng/mL     Release 2.77: COMPONENT: updated to the the anionic name ; 0
102066-8 Perfluorononanoate MCnc Ser/Plas Pt Qn LC/MS/MS   ACTIVE Perfluorononanoate [Mass/volume] in Serum or Plasma by LC/MS/MS   NAM DefinitionDescription     ng/mL             DRUG/TOX   102066-8   LC/MS/MS     Observation       0 PFNA SerPl LC/MS/MS-mCnc       N   DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; PFNA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.77 2.75               ng/mL     Release 2.77: COMPONENT: updated to the anionic name; 0
102067-6 Perfluoroheptane sulfonate MCnc Ser/Plas Pt Qn     ACTIVE Perfluoroheptane sulfonate [Mass/volume] in Serum or Plasma   NAM DefinitionDescription     ng/mL             DRUG/TOX   102067-6         Observation       0 PFHpS SerPl-mCnc       N   DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; PFHpS; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.77 2.75               ng/mL     Release 2.77: COMPONENT: updated to the anionic name per the Users' Guide section 2.1.2.13; 0
102068-4 Perfluoroundecanoate MCnc Ser/Plas Pt Qn LC/MS/MS   ACTIVE Perfluoroundecanoate [Mass/volume] in Serum or Plasma by LC/MS/MS   NAM DefinitionDescription     ng/mL             DRUG/TOX   102068-4   LC/MS/MS     Observation       0 PFUnDA SerPl LC/MS/MS-mCnc       N   DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; PFUnDA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.77 2.75               ng/mL     Release 2.77: COMPONENT: updated to the anionic name; 0
102069-2 Perfluorodecanoate MCnc Ser/Plas Pt Qn LC/MS/MS   ACTIVE Perfluorodecanoate [Mass/volume] in Serum or Plasma by LC/MS/MS   NAM DefinitionDescription     ng/mL             DRUG/TOX   102069-2   LC/MS/MS     Observation       0 PFDA SerPl LC/MS/MS-mCnc       N   DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; PFDA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.77 2.75               ng/mL     Release 2.77: COMPONENT: use the anionic name per the Users' Guide section 2.1.2.13; 0
10207-9 Physical findings Find Thorax+Lungs Pt Nar Observed   ACTIVE Physical findings of Thorax and Lungs Narrative   MIN DefinitionDescription                   H&P.PX   10207-9   Observed             0 Phys find Thorax+Lungs           Exam; Examination; Finding; Findings; H+P; H+P.PX; Narrative; P prime; Phys find; Point in time; Random; Report; Thoracic 2.4 1.0i                       0
102070-0 Perfluoromethylheptane sulfonate MCnc Ser/Plas Pt Qn LC/MS/MS   ACTIVE Branched PFOS Isomers [Mass/volume] in Serum or Plasma by LC/MS/MS   NAM DefinitionDescription     ng/mL             DRUG/TOX   102070-0   LC/MS/MS     Observation       0 Sm-PFOS SerPl LC/MS/MS-mCnc       N   DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sm-PFOS; SR 2.77 2.75               ng/mL     Release 2.77: COMPONENT: updated to the anionic name; 0
102071-8 n-Perfluorooctane sulfonate MCnc Ser/Plas Pt Qn LC/MS/MS   ACTIVE Linear PFOS Isomer [Mass/volume] in Serum or Plasma by LC/MS/MS   NAM DefinitionDescription     ng/mL             DRUG/TOX   102071-8   LC/MS/MS     Observation       0 n-PFOS SerPl LC/MS/MS-mCnc       N   DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; n-PFOS; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.77 2.75               ng/mL     Release 2.77: COMPONENT: changed to anionic name per Users' Guide section 2.1.2.13 ; 0
102072-6 2-N-Methyl-perfluorooctanesulfonamide acetate MCnc Ser/Plas Pt Qn LC/MS/MS   ACTIVE 2-N-Methyl-perfluorooctanesulfonamide acetate [Mass/volume] in Serum or Plasma by LC/MS/MS   NAM DefinitionDescription     ng/mL             DRUG/TOX   102072-6   LC/MS/MS     Observation       0 Me-PFOSA-AcOH SerPl LC/MS/MS-mCnc       N   Acetic acid; DRUG/TOXICOLOGY; Drugs; Ethanoate; Ethanoic acid; II; Level; Mass concentration; Me-PFOSA-AcOH; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.77 2.75               ng/mL     Release 2.77: COMPONENT: changed to anionic name per Users' Guide section 2.1.2.13; 0
102073-4 Perfluorododecanoate MCnc Ser/Plas Pt Qn LC/MS/MS   ACTIVE Perfluorododecanoate [Mass/volume] in Serum or Plasma by LC/MS/MS   NAM DefinitionDescription     ng/mL             DRUG/TOX   102073-4   LC/MS/MS     Observation       0 PFDoDA SerPl LC/MS/MS-mCnc       N   DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Perfluorolauric acid; PFDoA; PFDoDA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tricosafluorododecanoic acid 2.77 2.75               ng/mL     Release 2.77: COMPONENT: updated to the anionic name per the Users' Guide section 2.1.2.13; 0
102074-2 Perfluorooctane Sulfonamide MCnc Ser/Plas Pt Qn LC/MS/MS   ACTIVE Perfluorooctane Sulfonamide [Mass/volume] in Serum or Plasma by LC/MS/MS   ADD DefinitionDescription     ng/mL             DRUG/TOX   102074-2   LC/MS/MS     Observation       0 PFOSA SerPl LC/MS/MS-mCnc       N   C75; DRUG/TOXICOLOGY; Drugs; FOSA; Level; Mass concentration; Perfluorooctane sulfonamide; Perfluorooctanesulfonamide; PFOSA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Sulf; Sulfa; Sulfas; Sulfonamides 2.75 2.75               ng/mL       0
102075-9 NASEM Summation Value MCnc Ser/Plas Pt Qn     ACTIVE NASEM Summation Value [Mass/volume] in Serum or Plasma   ADD DefinitionDescription     ng/mL     Calculation: Sum of Sb-PFOA, PFOA, PFHxS, PFNA, PFDA, Sm-PFOS, PFOS, PFUnDA, MeFOSAA results.Summation suggested by: National Academies of Sciences, Engineering, and Medicine       DRUG/TOX   102075-9         Both       0 NASEM Summation Value SerPl-mCnc       N   DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.75 2.75               ng/mL       0
102076-7 Insulin^3.5H post 75 g glucose PO ACnc Ser/Plas Pt Qn     ACTIVE Insulin [Units/volume] in Serum or Plasma --3.5 hours post 75 g glucose PO   ADD DefinitionDescription     uIU/mL             CHAL   102076-7         Both       0 Insulin 3.5h p 75 g Glc PO SerPl-aCnc       N   3.5h p 75 g Glc PO; 75Gm; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; NPH; p 75 g Glc PO; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente 2.75 2.75               u[IU]/mL       0
102078-3 Chimeric antigen receptor T-cell therapy panel - XXX Pt -     ACTIVE CAR-T therapy panel - Specimen   ADD DefinitionDescription                   PANEL.DRUG/TOX   102078-3         Order       0 CAR-T panel Spec       N   Ag; CAR-T panel; DRUG/TOXICOLOGY; Drugs; Misc; Miscellaneous; Other; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; Rec; Recept; Receptors; Recp; Recptr; Spec; T cell; T prime; To be specified in another part of the message; UCHL-1; Unspecified 2.75 2.75   Panel                   0
102079-1 CAR-T dose NCnt ^Patient Pt Qn     ACTIVE CAR-T dose [#/mass]   ADD DefinitionDescription     10*6             DRUG/TOX   102079-1         Both       0 CAR-T dose Patient       N   Count/mass; DRUG/TOXICOLOGY; Drugs; Number content; Point in time; QNT; Quan; Quant; Quantitative; Random; T prime 2.75 2.75               10*6       0
10208-7 Physical findings Find Vessels Pt Nar Observed   ACTIVE Physical findings of Vessels Narrative   MIN DefinitionDescription                   H&P.PX   10208-7   Observed             0 Phys find Vesl           Exam; Examination; Finding; Findings; H+P; H+P.PX; Narrative; P prime; Phys find; Point in time; Random; Report; Vesl; Vessels.XXX 2.4 1.0i                       0
102080-9 CAR-T cell Type ^BPU Pt Nom     ACTIVE CAR-T cell [Type] in Blood product unit   ADD DefinitionDescription                   BLDBK   102080-9         Observation       0 CAR-T cell BPU       N   BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Nominal; Point in time; Random; T prime; Typ; UCHL-1 2.75 2.75                       0
102081-7 CAR-T cells.total Num ^BPU Pt Qn     ACTIVE CAR-T cells total [#] in Blood product unit   ADD DefinitionDescription     10*6             BLDBK   102081-7         Observation       0 CAR-T total BPU       N   BLOOD BANK; Blood product unit; Blood Product Unit (Pack); CAR-T total; Cell; Cellularity; Cnt; Count; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; T prime; Tot; Totl 2.75 2.75               10*6       0
102082-5 Alpha-1-Antitrypsin Proteotype panel - Ser/Plas Pt -     ACTIVE Alpha-1-Antitrypsin Proteotype Panel - Serum or Plasma   MIN DefinitionDescription                   PANEL.CHEM   102082-5         Order       0 A1AT Proteotype panel SerPl       N   A1; A1A; A1AT; A-1-AT; A1-AT; A1AT Proteotype panel; AAT; Alfa; Alpha-1-antitrypsin.total; Alpha-1-protease inhibitor; Alpha-1-proteinase inhibitor; Alpha-1-trypsin inhibitor; Chemistry; i; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.76 2.75   Panel                   0
104,672 results found